EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Indolenine-substituted pyrazole derivative 4e inhibits planktonic Staphylococcus lugdunensis growth and biofilm formation by disrupting purine biosynthesis and compromising cell wall and membrane integrity

Jazon Harl Hidrosollo iD, Hsiao-Wei Liao, Cheng Hong Yap iD, Jason Jonah James, Jang-Jih Lu iD, Yu-Hsien Tai, Chuancheng Wei, Tran Thi Dieu Thuy, Sek Peng Chin, Sun Tee Tay iD, Chin Fei Chee iD, Cheng Yen Kao iD

Antimicrobial Agents and Chemotherapy · 2025

DOI: 10.1128/aac.00199-25 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2025. Verfasst von Jazon Harl Hidrosollo und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei city, Taiwan. Hauptthemen laut MEDLINE: Biofilms, Anti-Bacterial Agents, Cell Wall, Staphylococcus lugdunensis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Universiti Malaya.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Staphylococcus lugdunensis is an emerging nosocomial pathogen responsible for biofilm-related infections. Here, we explored the antibacterial and antibiofilm properties of the novel indolenine derivative 4e against S. lugdunensis and investigated its mechanisms of action. Its antibacterial and antibiofilm activities were assessed against oxacillin-resistant S. lugdunensis CGMH-SL131 using in vitro and in vivo models, including human cell lines, Galleria mellonella larvae, and mice. Mechanistic insights were explored via untargeted metabolomics. 4e exhibited bacteriostatic activity against a panel of gram-positive bacteria, with a 1× minimum inhibitory concentration (MIC) of 62.5 µg/mL. Scanning electron microscope observations of cells treated with 0.5% SDS and 1× MIC 4e displayed signs of cell shape distortion, including complete shrinkage and bursting. 4e effectively inhibited biofilm formation by 54.3% at 1.56 µg/mL, and the minimum biofilm inhibition concentration 80% (MBIC 80 ) was 3.125 µg/mL. In addition, 70.3% of 1-day preformed biofilms were dispersed at 1× MBIC 80 . 4e exhibited low cytotoxicity (>85% survival) in HaCaT, H10975, and Caco-2 cells at 1× MIC. When administered 1 hour post-infection, 4e (3.125 mg/kg) improved larval survival to 90%, matching tigecycline (2 mg/kg), whereas untreated larvae had only 20% survival after 7 days. In C57BL/6 mice, 4e (2.5 mg/kg) reduced kidney bacterial loads from 10⁷ to 5.3 × 10⁴ CFU. Untargeted metabolomics suggests that 4e’s antibacterial and antibiofilm effects result from disrupting purine biosynthesis and compromising cell wall and membrane integrity. These findings highlight 4e as a promising new antibiofilm agent and potential alternative treatment for biofilm-related infections caused by S. lugdunensis and multidrug-resistant Staphylococcus species.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BiofilmsAnti-Bacterial AgentsCell WallStaphylococcus lugdunensisPurinesIndolesAnimalsMicrobial Sensitivity TestsHumansMiceCell MembraneLarvaStaphylococcal InfectionsPlankton

Stichwörter der Autor:innen

antibacterial activitybiofilm dispersal agentbiofilm inhibitionindolenine-substituted pyrazole derivativeoxacillin-resistant Staphylococcus lugdunensisuntargeted metabolomics

Substanzen

Anti-Bacterial AgentsPurinespurineIndoles

Autor:innen und Institutionen

  • Institute of Microbiology and Immunology, College of Life Sciences, National Yang Ming Chiao Tung University, Taipei city, Taiwan.
  • College of Pharmacy and Medical Technology, University of San Agustin, Iloilo, Philippines.
  • Department of Pharmacy, College of Pharmaceutical Sciences, National Yang Ming Chiao Tung University, Taipei city, Taiwan.
  • Department of Medical Microbiology, Faculty of Medicine, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Nanotechnology and Catalysis Research Centre, Universiti Malaya, Kuala Lumpur, Malaysia.
  • Division of Clinical Pathology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei city, Taiwan.

ORCID-Profile: Jazon Harl Hidrosollo, Cheng Hong Yap, Jang-Jih Lu, Sun Tee Tay, Chin Fei Chee, Cheng Yen Kao

Förderung

  • National Science and Technology Council
  • Universiti Malaya

Zitieren

APA

Hidrosollo, J. H., Liao, H. W., Yap, C. H., James, J. J., Lu, J. J., Tai, Y. H., Wei, C., Thuy, T. T. D., Chin, S. P., Tay, S. T., Chee, C. F., & Kao, C. Y. (2025). Indolenine-substituted pyrazole derivative 4e inhibits planktonic Staphylococcus lugdunensis growth and biofilm formation by disrupting purine biosynthesis and compromising cell wall and membrane integrity. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00199-25

Vancouver

Hidrosollo JH, Liao HW, Yap CH, James JJ, Lu JJ, Tai YH, et al. Indolenine-substituted pyrazole derivative 4e inhibits planktonic Staphylococcus lugdunensis growth and biofilm formation by disrupting purine biosynthesis and compromising cell wall and membrane integrity. Antimicrobial Agents and Chemotherapy. 2025. doi:10.1128/aac.00199-25

BibTeX
@article{Hidrosollo2025,
  author = {Hidrosollo, Jazon Harl and Liao, Hsiao-Wei and Yap, Cheng Hong and James, Jason Jonah and Lu, Jang-Jih and Tai, Yu-Hsien and Wei, Chuancheng and Thuy, Tran Thi Dieu and Chin, Sek Peng and Tay, Sun Tee and Chee, Chin Fei and Kao, Cheng Yen},
  title = {Indolenine-substituted pyrazole derivative 4e inhibits planktonic Staphylococcus lugdunensis growth and biofilm formation by disrupting purine biosynthesis and compromising cell wall and membrane integrity},
  journal = {Antimicrobial Agents and Chemotherapy},
  year = {2025},
  doi = {10.1128/aac.00199-25}
}
Kostenlos starten →